Spero Therapeutics, Inc.
SPRONASDAQHealthcare● Active
$2.81
+$0.07(+2.37%)
Market Cap$162413688
P/E Ratio—
52W High$3.22
52W Low$1.8
Spero Therapeutics, Inc. (SPRO) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SPRO · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $40.27M | $52.89M | $76.33M | $109.11M | $146.40M |
| Net Receivables | $25.39M | $52.48M | $50.70M | $1.08M | $2.64M |
| Inventory | $0.00M | $0.00M | $0.00M | ($4.46M) | $0.00M |
| Total Current Assets | $67.29M | $107.28M | $131.21M | $109.11M | $157.87M |
| PP&E Net | $1.48M | $3.11M | $4.16M | $5.49M | $7.56M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $68.92M | $110.54M | $182.39M | $124.80M | $171.07M |
| Liabilities | |||||
| Short-Term Debt | $1.96M | $0.00M | $1.72M | $0.00M | $0.00M |
| Accounts Payable | $0.69M | $7.31M | $1.38M | $0.62M | $1.10M |
| Total Current Liabilities | $8.87M | $49.07M | $37.15M | $21.65M | $18.67M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $9.90M | $64.42M | $75.50M | $48.87M | $82.78M |
| Stockholders Equity | |||||
| Retained Earnings | ($451.07M) | ($459.64M) | ($391.07M) | ($413.88M) | ($367.46M) |
| Total Stockholders Equity | $59.02M | $46.12M | $106.89M | $75.93M | $88.29M |
| Total Liab & Equity(computed) | $68.92M | $110.54M | $182.39M | $124.80M | $171.07M |
| Debt Summary | |||||
| Total Debt | $2.90M | $4.30M | $5.54M | $6.65M | $7.33M |
| Net Debt | ($37.37M) | ($48.59M) | ($70.79M) | ($102.46M) | ($105.25M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Spero Therapeutics, Inc. data
About Spero Therapeutics, Inc. (SPRO) Balance Sheet
Spero Therapeutics, Inc. (SPRO) balance sheet shows total assets of $0.07B with cash of $0.04B. Total liabilities are $0.01B, total debt $0.00B, and stockholders equity $0.06B.
Frequently asked questions
SPRO · 4 questionsSpero Therapeutics, Inc. has total debt of $0.00B with net debt of ($0.04B).
SPRO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10